Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the state of Gujarat. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world. An integrated healthcare solutions provider with pharmaceutical product basket, it caters to over 45 therapeutic areas that include cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals. The company focuses on providing high quality, appropriately priced products to its customers and supports all these with dedicated customer service. Cadila Pharmaceuticals has a multicultural, multilingual and multinational workforce of more than four thousand employees including over two hundred people outside India in forty-nine countries of Africa, CIS, Japan and USA.
The company has one of the best Research and Development (R&D) setups in India, manned by more than three hundred and fifty scientists and engineers from various disciplines including biology, pharmacology, clinical research, chemistry, toxicology, phytochemistry and different disciplines of engineering. The company also participates in Public-Private partnerships for developing diagnostic, preventive and curative pharmaceutical and diagnostic products.
Cadila Pharmaceuticals is the first Indian company to get IND approval by USFDA for clinical trials to be conducted in India. Subsequently, the company has filed four more INDs with USFDA. Of the five INDs filed, one is for pulmonary tuberculosis; the trial is supported by Department of Biotechnology, Govt. of India. The remaining four are for various types of cancers, e.g., Lung Cancer, Prostrate cancer, Bladder Cancer and Melanoma. Thus all the INDs are for providing solutions to major global health care problems. The clinical trials on Prostrate cancer, Lung cancer and Bladder cancer are supported by Department of Science and Technology to encourage innovations.
Abbott Laboratories is a pharmaceuticals health care company. It has 72,000 employees and operates in over 130 countries.The company headquarters are in Abbott Park, North Chicago, Illinois. The company was founded by Chicago physician, Dr. Wallace Calvin Abbott in 1888. In 2008, Abbott had over $29 billion in revenue.
In 1985, the company developed the first HIV blood screening test. The company's drug portfolio includes , a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis; Norvir, a treatment for HIV; Depakote, an anticonvulsant drug; and Synthroid, a synthetic thyroid hormone. Abbott also has a broad range of medical devices, diagnostics and immunoassay products as well as nutritional products, including Ensure, a line of well known meal replacement shakes, and EAS, the largest producer of performance based nutritional supplements.
Johnson & Johnson Ltd
Johnson & Johnson is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500.Johnson & Johnson consistently ranks at the top of Harris Interactive's National Corporate Reputation Survey, ranking as the world's most respected company by Barron's Magazine, and was the first corporation awarded the Benjamin Franklin Award for Public Diplomacy by the U.S. State Department for its funding of international education programs.[
Bristol Myers Squibb India Pvt Ltd
Bristol-Myers Squibb, often referred to as BMS, is a pharmaceutical company, headquartered in New York City. The company was formed in 1989, following the merger of its predecessors Bristol-Myers and the Squibb Corporation. Squibb was founded in 1858 by Edward Robinson Squibb in Brooklyn, New York, while Bristol-Myers was founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, New York (both were graduates of Hamilton College).
Lamberto Andreotti became the company's CEO on May 4, 2010. Former CEO James M. Cornelius remains chairman of the Board of Directors.
Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. Its mission is to "discover, develop and deliver innovative medicines that help patients prevail over serious diseases."
BMS' primary R&D sites are located in Princeton, New Jersey (formerly Squibb) and Wallingford, Connecticut (formerly Bristol-Myers), with other sites in Hopewell and New Brunswick, New Jersey, and in Braine-l'Alleud, Belgium, and Tokyo.
Hetro Healthcare Ltd
Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs.
Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
Eli-Lilly & Co (I) Pvt Ltd
Eli Lilly and Company is a global pharmaceutical company. Eli Lilly's global headquarters is located in Indianapolis,in the United States. The company was founded in 1876 by a pharmaceutical chemist, Eli Lilly, after whom the company was ultimately named.
Among other specialties, Lilly was the first company to mass-produce penicillin and today is the world's largest manufacturer and distributor of psychiatric medications.A Fortune 500 corporation, Eli Lilly had revenues of $20 billion in 2008, making it the 148th largest company in the United States and the 10th largest corporation by global pharmaceutical sales.
Strides Arcolab Ltd
Incorporated in 1990, Strides Arcolab is a first generation, pharmaceutical company headquartered in Bangalore, India. With business interests in specialty pharmaceuticals, pharma generics and branded generics, we are a valued player in the global healthcare industry.
With world-class manufacturing operations in 14 global locations, an innovative R&D hub in Bangalore and a marketing network in 70 countries, they are well positioned to meet the growing demands and challenges of the global pharmaceutical industry. Their key focus is on the development and manufacture of IP-led niche pharmaceutical products with an emphasis on sterile injectables. They are also among the world's largest soft gelatin capsule manufacturers.
Cipla Limited is a prominent Indian pharmaceutical company. Founded by Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories in 1935, Cipla makes drugs to treatanti-cancer, cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions, and its products are distributed in more than 180 countries worldwide.
V.H.B Lifesciences Ltd
News Update Rewarded IDMA Quality Excellence award 2009 WHO GMP Certified Facility INVIMA Approved Facility Launch of RD Technology Products Initiation of PFS Facility Foundation for General Products Facility
VHB Life Sciences Limited has taken birth six decades back, spearheading its foray into manufacturing & marketing of wide range of therapeutic formulations year after year. It has emerged as India's fastest growing and most reputed pharma company. VHB Life Sciences Limited has to its credit 6 integrated independent SBU's.
History has a special mention of VHB Group, for over six decades now since its inception in 1946, it has to its credit the introduction of a wide range of highly specialized innovative formulations 15 of which hold the Numero Uno position in India and globally.
Currently VHB Group. is rated as the fastest growing pharmaceutical organization. The vision that it has believed in "to Save Lives Through Life Saving Drugs" has earned it tremendous goodwill of being a respected and reputed name in India since 1946...
Reliance Life Sciences Ltd
Reliance Life Sciences Reliance Life Sciences is a new millennium initiative of the Reliance Group of companies.
The vision of Reliance Life Sciences is to attain global leadership through innovative and cost-effective solutions for a better life.
Reliance Group is the largest private sector enterprise in India, participating in businesses in the energy and materials value chain, with group revenues of USD 29 billion. The flagship company, Reliance Industries Limited, is a Fortune Global 500 company.
Reliance Life Sciences is a research-driven, biotechnology-led, life sciences organization. Reliance Life Sciences participates in medical, plant and industrial biotechnology opportunities. Specifically, these relate to Biopharmaceuticals, Pharmaceuticals, Clinical Research Services, Regenerative Medicine, Molecular Medicine, Novel Therapeutics, Biofuels, Plant Biotechnology and Industrial Biotechnology.
Intas Biopharmaceutical Ltd
Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.
Intas's success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R & D, Biotechnology and global operations over three decades. Today, Intas is a $350 million organization with overall 35% CAGR growth over the last 4 years and is ranked as the 12th largest pharmaceutical company in the domestic market. (as per IMS Health India, Secondary Stockist Audit (SSA), April 2011)
Miraculus Pharma Pvt Ltd
They are a world class manufacturer of Parenterals, Tablets, Capsule Formulations and General / Sterile APIs.
They have proven, market-leading expertise in Lyophilization ( Freeze drying technology. )
Their USP lies in leadership in lyophilized formulations for oncology applications.
Their current production facility and quality systems meet WHO as well as other international requirements of GMP
Fresenius Kabi Oncology Limited specialises in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing and distribution set up. Over the years the company has emerged as global player in the field of oncology by providing high quality products at affordable prices supported by superior customer service. The company has world class expertise for development and manufacturing of Active Pharmaceutical Ingredients (API), intermediates and dosage forms. From the development of process technology to filing of DMFs, we have full range of capabilities that would suffice various needs of our patients. All our activities are carried out in-house supported by stringent analytical and testing capabilities. Today, Fresenius Kabi Oncology Limited is synonymous with quality. It is this high standard and endeavour for perfection, which has built a bond of trust between Fresenius Kabi Oncology Limited and its consumers.
To,Impex India, Anti Cancer Medicine